NSPR.NASDAQInspiremd, INC

SCHEDULE 13G/A: Nantahala Capital Management Discloses 9.99% Stake in InspireMD, Inc.

Sentiment:

Beneficial Ownership Disclosure


Nantahala Capital Management, along with its managing members Wilmot B. Harkey and Daniel Mack, has disclosed a beneficial ownership of 9.99% in InspireMD, Inc., totaling 2,709,118 shares as of December 31, 2024.

Summary

  • Nantahala Capital Management, LLC, an investment adviser, and its managing members, Wilmot B. Harkey and Daniel Mack, collectively reported beneficial ownership of 2,709,118 shares of InspireMD, Inc. common stock.
  • This ownership represents 9.99% of InspireMD, Inc.'s outstanding common stock as of December 31, 2024.
  • The reported shares include 1,034,553 shares that can be acquired by the Reporting Persons within sixty days through the exercise of warrants.
  • Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack share both voting and dispositive power over all 2,709,118 shares.
  • The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of InspireMD, Inc.
  • Two funds advised by Nantahala, NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP and BLACKWELL PARTNERS LLC SERIES A, each hold more than five percent of the outstanding shares beneficially owned by Nantahala.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook. It is a standard regulatory filing.

Future Outlook

NA

Industry Context

This Schedule 13G filing indicates a significant passive investment by an institutional investor, Nantahala Capital Management, in InspireMD, Inc. Such filings provide transparency on major ownership stakes, which can be a signal of institutional confidence or interest in a company within the medical device or healthcare sector, where InspireMD operates.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional ownership stake, which can influence investor perception and potentially liquidity.
  • Company Management: Awareness of a large institutional holder, though the filing states the stake is passive and not for control purposes.

Key Dates

DateDescription
12/31/2024Date of event which required the filing of this statement, reflecting the beneficial ownership snapshot.
02/14/2025Date the Schedule 13G/A filing was signed and submitted.

Keywords

InspireMD Inc., Nantahala Capital Management, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Wilmot B. Harkey, Daniel Mack, Warrants

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.